The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of a phase I study of bispecific anti-CD19, anti-CD20 chimeric antigen receptor (CAR) modified T cells for relapsed, refractory, non-Hodgkin lymphoma.
 
Nirav Niranjan Shah
Stock and Other Ownership Interests - Cidara Therapeutics; Exelixis; Geron; Oncosec
Consulting or Advisory Role - Incyte; Jazz Pharmaceuticals; Juno Therapeutics; Kite, a Gilead company
Research Funding - Miltenyi Biotec
Travel, Accommodations, Expenses - Miltenyi Biotec
 
Fenlu Zhu
No Relationships to Disclose
 
Dina Schneider
Employment - Lentigen
Patents, Royalties, Other Intellectual Property - Lentigen Technology, Inc., a Miltenyi Biotec Company, patents in the CAR-T field
Travel, Accommodations, Expenses - Cambridge Healthtech Institute
 
Carolyn Taylor
No Relationships to Disclose
 
Winfried Krueger
Employment - Lentigen Technology
 
Andrew Worden
Employment - Lentigen Technology
 
Walter L. Longo
No Relationships to Disclose
 
Mehdi Hamadani
Honoraria - Celgene
Consulting or Advisory Role - ADC Therapeutics; Cellerant Therapeutics; Incyte; Janssen Research & Development; MedImmune; Pharmacyclics; Puma Biotechnology (I)
Speakers' Bureau - Celgene; Genzyme
Research Funding - Astellas Pharma; Genzyme; Genzyme; Otsuka; Spectrum Pharmaceuticals; Takeda
 
Timothy Fenske
Stock and Other Ownership Interests - Merck
Honoraria - Adaptive Biotechnologies; AstraZeneca; Celgene; Genentech; Janssen Oncology; Sanofi/Aventis; Seagen
Consulting or Advisory Role - Adaptive Biotechnologies; Genentech; Janssen Oncology; Seagen
Speakers' Bureau - AstraZeneca; Celgene; Sanofi/Aventis; Seagen
Travel, Accommodations, Expenses - Adaptive Biotechnologies; AstraZeneca; Celgene; Genentech; Janssen Oncology; Sanofi/Aventis; Seagen
 
Bryon Johnson
Research Funding - Lentigen Technology
 
Boro Dropulic
Employment - Lentigen Technology
 
Rimas Orentas
Employment - Lentigen Technology
Consulting or Advisory Role - Lentigen Technology
Patents, Royalties, Other Intellectual Property - Lentigen Technology, Inc., a Miltenyi Biotec Company, patents in the CAR-T field; U.S.A., Department of Heath and Human Services, patents and licensing for CAR-T inventions
Travel, Accommodations, Expenses - Cambridge Healthtech Institute; Juno Therapeutics
 
Parameswaran Hari
Honoraria - Amgen; Celgene; Juno Therapeutics; Novartis; Sanofi; Spectrum Pharmaceuticals
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Kite, a Gilead company; Sanofi; Spectrum Pharmaceuticals; Takeda
Research Funding - Celgene (Inst); Millennium (Inst); Onyx (Inst); Spectrum Pharmaceuticals (Inst)